Kulkarni Samarth Insider Trades & Stock Holdings

Chief Executive Officer · CRISPR Therapeutics AG · Latest filing Oct 14, 2026

Kulkarni Samarth, Chief Executive Officer at CRISPR Therapeutics AG has 1 Form 4 trade on file since Oct 14, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($201.87K), net -$201.87K. Latest filing: disposed of 4.10K shares of $CRSP on Oct 14, 2026 at $49.26.

Trades on file

1

Open-market bought

$0

Open-market sold

$201.87K

Net open-market

-$201.87K

Latest filing

Oct 14, 2026

All insider trades by Kulkarni Samarth

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 14, 2026	$CRSP	Sell (Open-market sale)	4.10K	$49.26	$201.87K						Chief Executive Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Kulkarni Samarth traded

• $CRSP

Frequently asked questions

Has Kulkarni Samarth been buying or selling stock?

Kulkarni Samarth has 0 open-market purchases and 1 open-market sale on file, net -$201.87K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Kulkarni Samarth's latest insider trade?

disposed of 4.10K shares of $CRSP on Oct 14, 2026 at $49.26.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.